H. Miayake

Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides.

M. Gleave, J. Goldie, A. Tolcher, 1999, Urology.

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.

M. Gleave, A. Tolcher, H. Miayake, 2000, Journal of the National Cancer Institute.